Catsci Invest Ltd
Activities of other holding companies n.e.c. · Cardiff
ActiveUnited KingdomIncorporated 2022Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Group accounts
Net assets
£8,301,224
Cash
£3,112,473
Turnover
£12,953,732
Profit / loss
−£15,280,098
Current assets
£6,546,841
Creditors < 1 year
£2,766,896
Equity
£8,301,224
Average employees
Not available
Balance-sheet trend
GBP · consolidatedFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Group · AI-read | 2024-12-31Group · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | £8,301,224 | £23,478,800 |
| Equity | £8,301,224 | £23,478,800 |
| Share capital | £9,401 | £9,401 |
| Retained earnings | −£40,994,815 | −£25,674,654 |
| Assets | ||
| Fixed assets | £16,258,441 | £28,742,276 |
| Intangible assets | £10,466,864 | £22,348,080 |
| Property, plant & equipment | £5,779,240 | £6,381,859 |
| Investments | £12,337 | £12,337 |
| Current assets | £6,546,841 | £7,426,742 |
| Cash at bank | £3,112,473 | £3,304,528 |
| Debtors | £3,318,946 | £4,042,542 |
| Stock | £115,422 | £79,672 |
| Liabilities | ||
| Creditors within one year | £2,766,896 | £2,845,117 |
| Creditors after one year | £11,303,927 | £9,344,779 |
| Bank loans & overdrafts | £1,911,016 | £2,820,427 |
| Provisions | — | £500,322 |
| Capital commitments | £84,129 | — |
| Net current assets | £3,779,945 | £4,581,625 |
| Assets less current liabilities | £20,038,386 | £33,323,901 |
| Profit & loss | ||
| Turnover | £12,953,732 | £11,814,716 |
| Cost of sales | £6,302,004 | £4,936,407 |
| Gross profit | £6,651,728 | £6,878,309 |
| Administrative expenses | £13,209,909 | £12,365,793 |
| Other operating income | £1,169,553 | £825,541 |
| Operating profit | −£5,388,628 | −£4,661,943 |
| Interest receivable | £406,865 | £249,364 |
| Interest payable | £1,322,469 | £1,445,315 |
| Profit before tax | −£15,035,014 | −£17,630,986 |
| Tax | −£245,084 | £55,583 |
| Profit / loss | −£15,280,098 | −£17,575,403 |
| Operating costs | ||
| Depreciation | £2,034,763 | £1,585,819 |
| Amortisation | £3,187,745 | £4,553,951 |
| Operating lease charges | £560,154 | £683,931 |
| Audit fees | £52,063 | £58,142 |
| Cash flow | ||
| Net debt | £9,289,562 | — |
| People & pay | ||
| Staff costs | £6,849,613 | £6,336,972 |
| Wages & salaries | £5,438,688 | £5,074,907 |
| Social security costs | £774,885 | £637,395 |
| Pension costs | £493,455 | £486,216 |
| Directors' remuneration | £551,882 | £543,434 |
| Highest paid director | £172,598 | £142,094 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Clean (unmodified)
- Accounts
- Full accounts · FRS 102
- Approved
- 2026-05-19, signed by Dr R T Burn
Subsidiaries (5)
- CatSci Holdings Ltd* · 100 % · CBTC2 Capital Business Park, Wentloog, Cardiff, CF3 2PX · Holding Company
- Capital Drug Development Ltd* · 100 % · CBTC2 Capital Business Park, Wentloog, Cardiff, CF3 2PX · Holding Company
- CatSci Ltd · 100 % · CBTC2 Capital Business Park, Wentloog, Cardiff, CF3 2PX · Other research and experimental development on natural sciences and engineering
- Reach Separations Ltd* · 100 % · Biocity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF · Chromatography for the analysis and purification of small molecules
- Reach Separations SAS · 100 % · 16, rue d'Ankara, 67080, Strasbourg, France · Chiral development and analysis
Turnover by segment (10)
- Services provided: 12,953,732 (2025-12-31)
- Sale of goods: 6,532 (2024-12-31)
- United Kingdom: 1,693,202 (2025-12-31)
- Rest of Europe: 1,000,290 (2025-12-31)
- United States: 10,196,857 (2025-12-31)
- Rest of the World: 63,383 (2025-12-31)
- United Kingdom: 1,579,295 (2024-12-31)
- Rest of Europe: 1,143,538 (2024-12-31)
- United States: 8,971,670 (2024-12-31)
- Rest of the World: 120,213 (2024-12-31)
Related parties (4)
- Argonaute RNA Ltd · A company associated with CatSci Ltd with a common director and shareholders within CatSci Ltd's Directors · Sales; year-end amount outstanding · £124,491; £13,340
- LabLinks Ltd · A company associated with CatSci Ltd with a common director and shareholders within CatSci Ltd's Key Management Personnel · Sales and purchases; outstanding debtor and creditor balances · £nil sales; £12,000 purchases; £nil debtor; £7,200 creditor
- Reach Industries Ltd · A company associated with CatSci Ltd with shareholders within CatSci Ltd's Key Management Personnel · Purchases; year-end amount outstanding · £41,400; £3,600
- Close family member of a member of Key Management Personnel/Directors · Employment; paid at arm's length
Borrowings (2)
- Bank loan: five year term loan, drawn in March 2022 · £1,911,016 · Variable interest rate of 10-15% · Required to be paid in full by March 10, 2027; £3.6m plus related interest in equal monthly instalments from first anniversary; £900k capital plus interest as a single payment on March 10, 2027
- Other loans · 9,626,770 · Amounts falling due after more than 5 years
Share classes (6)
- 310,000 A1 Ordinary shares of £0.01
- 590,000 A2 Ordinary shares of £0.01
- 62,000 B Ordinary shares of £0.001
- 15,500 C Ordinary shares of £0.001
- 15,500 D Ordinary shares of £0.001
- 30,695,824 A Preference shares of £0.00001
Events after the year end (2)
- On 12 February 2026, CatSci Ltd refinanced its existing bank loan with Growth Lending 2021 Limited; the existing loan was repaid in full and a new loan for £2,700,000 was received.
- Subsequent to the year end, proceedings commenced for the voluntary closure and wind up of Reach Separations SAS.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
1 outstanding chargesFloating · created 2026-02-12
—
OutstandingShow 1 satisfied / released
All Assets · created 2022-07-01 · satisfied 2026-04-15
—
Satisfied